Cohen S M, Greenfield R E, Ellwein L B
Environ Health Perspect. 1983 Mar;49:209-15. doi: 10.1289/ehp.8349209.
The induction of cancer of the urinary bladder is a multi-stage process involving multiple exogenous and endogenous factors. Based on the classical initiation-promotion model, we have used N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) as initiator and sodium saccharin (SAC) or tryptophan as promoters. These latter chemicals have the properties expected of promoters: induction of hyperplasia, reversibility and nonmutagenicity. Also, tumors were induced whether the promoter was administered immediately after FANFT or beginning 6 weeks after FANFT was discontinued, but no tumors resulted if either promoter was given without initiation with FANFT. Factor(s) present in normal urine also are involved in the promotion process, in addition to the role of urine as a carrier of carcinogens. However, administration of SAC to animals with a rapidly proliferating bladder mucosa, induced by ulceration, pellet insertion, or in utero, resulted in bladder tumor induction, even without prior initiation with FANFT. To better understand the complex interaction of the multiple variables in bladder carcinogenesis, a stochastic computer model has been formulated based on long-term carcinogenicity and tissue kinetic studies in vivo. This model indicates the importance of cell proliferation and the development of hyperplasia in carcinogenesis.
膀胱癌的诱发是一个多阶段过程,涉及多种外源性和内源性因素。基于经典的启动-促进模型,我们使用N-[4-(5-硝基-2-呋喃基)-2-噻唑基]甲酰胺(FANFT)作为启动剂,用糖精钠(SAC)或色氨酸作为促进剂。后两种化学物质具有促进剂预期的特性:诱导增生、可逆性和非致突变性。此外,无论促进剂是在FANFT之后立即给药,还是在FANFT停药6周后开始给药,都会诱发肿瘤,但如果在没有用FANFT启动的情况下单独给予任何一种促进剂,则不会产生肿瘤。除了尿液作为致癌物载体的作用外,正常尿液中存在的因子也参与促进过程。然而,对因溃疡、植入小球或子宫内因素导致膀胱黏膜快速增殖的动物给予SAC,即使没有事先用FANFT启动,也会诱发膀胱肿瘤。为了更好地理解膀胱癌发生过程中多个变量的复杂相互作用,基于长期体内致癌性和组织动力学研究,建立了一个随机计算机模型。该模型表明了细胞增殖和增生发展在致癌过程中的重要性。